Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery

被引:17
作者
Kleemann, Elke [1 ,2 ]
Jekel, Norman [2 ]
Dailey, Lea Ann [1 ]
Roesler, Susanne [1 ,2 ]
Fink, Ludger [2 ]
Weissmann, Norbert [2 ]
Schermuly, Ralph [2 ]
Gessler, Tobias [2 ]
Schmehl, Thomas [2 ]
Roberts, Clive J. [3 ]
Seeger, Werner [2 ]
Kissel, Thomas [1 ]
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35037 Marburg, Germany
[2] UGLC, Giessen, Germany
[3] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England
关键词
Low-molecular-weight PEI; pulmonary gene delivery; transfection efficiency; intratracheal instillation; cytotoxicity; DNA/TRANSFERRIN-PEI COMPLEXES; DNA DELIVERY; IN-VITRO; MODIFIED POLYETHYLENIMINES; BRANCHED POLYETHYLENIMINE; TRANSFECTION EFFICIENCY; TRANSGENE EXPRESSION; NONVIRAL VECTOR; MOUSE LUNG; THERAPY;
D O I
10.1080/10611860903106414
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to elicit improved gene expression and decreased cytotoxicity for pulmonary gene therapy by replacing the commonly used carrier 25 kDa branched poly(ethylene imine) (BPEI) by two PEI derivatives, low-molecular-weight PEI (LMWPEI) and polyethylene glycol-grafted PEI (PEGPEI). All polymers were shown to condense DNA to spherical particles of approximately 100 nm. Biocompatibility was investigated in vitro and in vivo. Although transfection was less efficient with LMWPEI-DNA in vitro, this polyplex caused the highest luciferase expression in the mouse lung after intratracheal instillation. While PEGPEI luciferase expression in vitro was approximately three times higher when compared to BPEI, a transfection rate at the level of naked DNA was observed in vivo. LMWPEI polyplexes were located in both the bronchial and alveolar cells, whereas BPEI polyplexes were mainly detected in bronchial cells. LMWPEI combines low cytotoxicity with high transfection efficiency in the mouse lung in vivo, rendering it a promising strategy for pulmonary gene delivery.
引用
收藏
页码:638 / 651
页数:14
相关论文
共 45 条
[11]   In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. [J].
Fischer, D ;
Li, YX ;
Ahlemeyer, B ;
Krieglstein, J ;
Kissel, T .
BIOMATERIALS, 2003, 24 (07) :1121-1131
[12]  
FISCHER D, 2000, BIOMATERIALS DRUG DE, P195
[13]   Gene therapy: The first two decades and the current state-of-the-art [J].
Flotte, Terence R. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (02) :301-305
[14]   Gene therapy progress and prospects: Recombinant adeno-associated virus (rAAV) vectors [J].
Flotte, TR .
GENE THERAPY, 2004, 11 (10) :805-810
[15]   Gene therapy in cystic fibrosis [J].
Flotte, TR ;
Laube, BL .
CHEST, 2001, 120 (03) :124S-131S
[16]  
Freimark BD, 1998, J IMMUNOL, V160, P4580
[17]   Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery [J].
Gautam, A ;
Densmore, CL ;
Xu, B ;
Waldrep, JC .
MOLECULAR THERAPY, 2000, 2 (01) :63-70
[18]   Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes [J].
Gautam, A ;
Densmore, CL ;
Golunski, E ;
Xu, B ;
Waldrep, JC .
MOLECULAR THERAPY, 2001, 3 (04) :551-556
[19]   Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy [J].
Gautam, A ;
Densmore, CL ;
Waldrep, JC .
GENE THERAPY, 2001, 8 (03) :254-257
[20]   The development of gene therapy for diseases of the lung [J].
Gill, DR ;
Davies, LA ;
Pringle, IA ;
Hyde, SC .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (03) :355-368